» Articles » PMID: 23610237

Venous Thromboembolism in Elderly High-risk Medical Patients: Time Course of Events and Influence of Risk Factors

Overview
Publisher Sage Publications
Date 2013 Apr 24
PMID 23610237
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Venous thromboembolism (VTE) causes significant morbidity and mortality in hospitalized medical populations; however, medical patients do not currently receive thromboprophylaxis beyond their hospital stay. We reviewed the real-life occurrence of VTE-related care for 100 days post-hospitalization in Calgary, Canada. Using medical visit records with a unique patient identifier number applied throughout the city's hospitals, 989 high-risk patients were selected for review. Almost three-quarters of the elderly patients received appropriate prophylaxis while in hospital, and only 2% received prophylaxis on discharge. Over the 100-day follow-up, 21% of the patients presented with clinically suspected VTE, of which 3.8% had confirmed VTE. Patients with multiple risk factors (≥ 3) had the highest frequency of confirmed VTE (≥ 6.1%). This study suggests that the actual rate of VTE-related follow-up care in patients post-hospitalization is high in the first 100 days, particularly among those who have multiple risk factors, warranting consideration of extended thromboprophylaxis in this population.

Citing Articles

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial.

Spyropoulos A, Goldin M, Ageno W, Albers G, Elliott C, Hiatt W TH Open. 2022; 6(3):e177-e183.

PMID: 36046208 PMC: 9273326. DOI: 10.1055/s-0042-1750379.


Challenges of extended venous thromboembolism prophylaxis in medical and surgical patients.

Chindamo M, Paiva E, do Carmo Jr P, Rocha A, Marques M J Vasc Bras. 2022; 21:e20210195.

PMID: 35836745 PMC: 9250351. DOI: 10.1590/1677-5449.202101951.


The Role of Heparin in COVID-19: An Update after Two Years of Pandemics.

Mangiafico M, Caff A, Costanzo L J Clin Med. 2022; 11(11).

PMID: 35683485 PMC: 9180990. DOI: 10.3390/jcm11113099.


Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study.

Bruno X, Koh I, Lutsey P, Walker R, Roetker N, Wilkinson K J Thromb Haemost. 2022; 20(7):1645-1652.

PMID: 35426248 PMC: 9247009. DOI: 10.1111/jth.15729.


Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis.

Rungjirajittranon T, Owattanapanich W, Leelakanok N, Sasijareonrat N, Suwanawiboon B, Chinthammitr Y Clin Appl Thromb Hemost. 2021; 27:10760296211069082.

PMID: 34907791 PMC: 8689619. DOI: 10.1177/10760296211069082.